SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases
SAPHIR
Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases
1 other identifier
observational
600
3 countries
96
Brief Summary
A prospective, longitudinal, multicentre, observational cohort follow-up study conducted in France.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2022
Typical duration for all trials
96 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2022
CompletedFirst Posted
Study publicly available on registry
October 28, 2022
CompletedStudy Start
First participant enrolled
November 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedJune 12, 2024
July 1, 2023
2.9 years
October 25, 2022
June 10, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Persistence of the biosimilar
Persistence of the biosimilar is defined as the maintenance of FK adalimumab for the twelve-month study period
Month 12
Discontinuation of the biosimilar
Discontinuation of the biosimilar is defined as the definitive cessation of FK adalimumab
Month 12
Secondary Outcomes (7)
Clinical status
Day 0
Maintenance of therapeutic benefit
Month 6
Maintenance of therapeutic benefit
Month 12
Treatment acceptance
Day 0
Quality of life assessment
Month 12
- +2 more secondary outcomes
Study Arms (1)
Cohort
Adult patients who agreed to initiate treatment with a biosimilar (adalimumab FK) or to replace the reference adalimumab with the adalimumab FK biosimilar
Eligibility Criteria
Patients treated with adalimumab for chronic inflammatory rheumatism (CIR) or inflammatory bowel disease (IBD).
You may qualify if:
- Patient aged 18 years or over
- Patient who have been informed of the objectives and the conditions of the study and who did not object to its participation
- Patient diagnosed with one chronic inflammatory rheumatological (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis) or chronic inflammatory bowel (Crohn's disease, ulcerative colitis) diseases
- Or to initiate adalimumab by prescribing a biosimilar (Adalimumab FK)
- Either to replace Humira® with a biosimilar (AdalimumabFK)
You may not qualify if:
- Patient refusing or unable to comply with the study follow-up procedures (patient not contactable by telephone, unable to complete the self-administered questionnaire, or having poor French language skills, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (96)
Nouvelle Clinique BONNEFON
Alès, 30100, France
Ch Amiens Nord
Amiens, 80054, France
Chu Amiens Picardie Site Sud
Amiens, 80054, France
Cabinet Médical
Argeles, 66700, France
Ch Armentieres
Armentières, 59280, France
CH d'ARDECHE MERDIONALE
Aubenas, 07200, France
Cabinet de Gastroentérologie
Bayonne, 64100aa, France
Cabinet Médical
Besançon, 25000, France
Chu Besancon Hopital Jean Minjoz
Besançon, 25000, France
Clinique du Cèdre
Bois-Guillaume, 76230, France
AP HP Ambroise PARE
Boulogne-Billancourt, 92100, France
Ch Boulogne Sur Mer
Boulogne-sur-Mer, 62321, France
Hôpital Privé SAINT-MARTIN
Caen, 14050, France
Centre Consultations Polyclinique St Jean
Cagnes-sur-Mer, 06800, France
Ch Cahors
Cahors, 46000, France
Infirmerie Protestante de Lyon
Caluire-et-Cuire, 69641, France
Clinique du Parc
Castelnau-le-Lez, 34170, France
Ch Chateauroux
Châteauroux, 36019, France
Cabinet Médical
Chilly-Mazarin, 91380, France
CHU CLERMONT FERRAND, site ESTAING
Clermont-Ferrand, 63000, France
Chu Gabriell Monpied
Clermont-Ferrand, 63000, France
AP HP Hôpital BEAUJON
Clichy, 92110, France
Ch Sud Francilien
Corbeil-Essonnes, 91100, France
Clinique Claude BERNARD
Ermont, 95120, France
Chu Grenoble Sud
Échirolles, 38130, France
Ch Annecy Genevois
Épagny, 74370, France
Centre Gastro Loire
Gien, 45500, France
Ch Haguenau
Haguenau, 67504, France
Cabinet Médical
La Madeleine, 59110, France
Forum Médica
Lattes, 34970, France
Ch Chartres Louis Pasteur
Le Coudray, 28630, France
Cabinet Médical Groupe
Le Folgoët, 29260, France
AP HP Hôpital BICETRE
Le Kremlin-Bicêtre, 94270, France
Cabinet Médical de Rhumatologie
Lézignan-Corbières, 11200, France
Chu Dupuytren 2
Limoges, 87042, France
Ch Bretagne Sud
Lorient, 56322, France
Medipole de La Meurthe - Cabinet Médical
Lunéville, 54300, France
Cabinet Médical TILSITT
Lyon, 69002, France
Hopital Prive Jean Mermoz Cabinet Medica
Lyon, 69008, France
Maison Médicale
Marolles-en-Brie, 94440, France
Centre Mutualiste LA FEUILLERAIE
Marseille, 13004, France
AP HM Hôpital NORD
Marseille, 13015, France
Cabinet de Rhumatologie
Mennecy, 91540, France
Ch Montauban
Montauban, 82000, France
Clinique PONT DE CHAUME
Montauban, 82000, France
MIMOUNE
Montereau-Fault-Yonne, 77130, France
Ghi Le Raincy Montfermeil
Montfermeil, 93370, France
Chu Hôtel Dieu
Nantes, 44093, France
Institut Des Mici-Clinique Ambroise Paré
Neuilly-sur-Seine, 92 200, France
Cabinet Médical
Nice, 06000, France
Chu Nice Hôpital Pasteur
Nice, 06000, France
AP HP Hôpital LARRIBOISIERE
Paris, 75010, France
AP HP Hôpital SAINT ANTOINE
Paris, 75012, France
Cabinet Médical
Paris, 75012, France
Ap Hp Gh Pitie Salpetriere
Paris, 75013, France
Cabinet Médical
Paris, 75013, France
Chu Cochin
Paris, 75014, France
Chu Bichat
Paris, 75018, France
Ch Lyon Sud
Pierre-Bénite, 69495, France
Cabinet Médical
Poissy, 78300, France
Cabinet Médical
Poitiers, 86000, France
Clinique CROIX du SUD
Quint-Fonsegrives, 31130, France
Hôpital Robert DEBRE
Reims, 51092, France
Chu Pontchaillou
Rennes, 35033, France
Cabinet Médical
Rodez, 12000, France
Cabinet Médical
Saint-Amand-les-Eaux, 59230, France
Hôpital St-Avold Groupe Sos Santé
Saint-Avold, 57500, France
Chu Saint Etienne Hôpital Nord
Saint-Etienne, 42055, France
Cabinet Médical
Saint-Louis, 68300, France
Hôpital d'Instruction des Armées BEGIN
Saint-Mandé, 94160, France
Cabinet Médical
Sarreguemines, 57200, France
Cabinet Médical
Sarreguemines, 57200, France
Cabinet Médical
Strasbourg, 6700, France
Cabinet Médical
Strasbourg, 6700, France
Ch Strasbourg Hôpital Hautepierre
Strasbourg, 6700, France
Nouvel Hôpital Civil
Strasbourg, 67091, France
Ch Tarbes Lourdes
Tarbes, 65013, France
Hôpital Bel Air
Thionville, 57126, France
Cabinet Médical
Toulon, 83000, France
HIA Hôpital SAINT-ANNE
Toulon, 83800, France
CHU PURPAN Hôpital PIERRE PAUL RIQUET
Toulouse, 31059, France
Chu Rangueil
Toulouse, 31059, France
Clinique PASTEUR
Toulouse, 31076, France
Clinique MEDIPOLE GARONNE
Toulouse, 31100, France
Clinique PASTEUR
Toulouse, 31300, France
Cabinet Médical
Tourcoing, 59200, France
Centre Rééd. Fonct. Trestel - Ch Lannion
Trévou-Tréguignec, 22660, France
Hpda Site Clinique Générale
Valence, 26000, France
Cabinet de Rhumatologie
Valenciennes, 59300, France
Cabinet Médical
Vannes, 56000, France
Cabinet Médical
Vannes, 56000, France
Ghm Les Portes Du Sud
Vénissieux, 69200, France
Ch Villeneuve Pôle de Sante Villeneuvois
Villeneuve-sur-Lot, 47305, France
Cabinet Médical
Villeurbanne, 69100, France
Cabinet Médical
Pointe-à-Pitre, 97110, Guadeloupe
Cabinet Médical
Saint-Pierre, 97410, Martinique
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2022
First Posted
October 28, 2022
Study Start
November 24, 2022
Primary Completion
September 30, 2025
Study Completion
December 30, 2025
Last Updated
June 12, 2024
Record last verified: 2023-07